Stay updated on Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Sign up to get notified when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.

Latest updates to the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page
- Check7 days agoChange DetectedLocations section updated to include a comprehensive list of trial site states; old state listings were removed and a new Revision: v3.3.3 tag appears.SummaryDifference2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedPublications section now notes that publications are automatically filled from PubMed, replacing the previous wording. Revision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check43 days agoChange DetectedThe funding-status notice on the page was removed. The study record content and navigation remain unchanged.SummaryDifference0.2%

- Check57 days agoChange DetectedMinor layout and styling adjustments observed; core study content and the list of locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check86 days agoChange DetectedAdded a government funding status notice and a new version tag (v3.2.0); removed a specific resource (Hb SS disease) and the previous version tag (v3.1.0).SummaryDifference4%

- Check93 days agoChange DetectedUpdate of chemical/material taxonomy and nomenclature, with a new revision tag (v3.1.0) replacing older terms from v3.0.2.SummaryDifference1%

Stay in the know with updates to Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poloxamer 188 in Sickle Cell Vaso-Occlusion Clinical Trial page.